Clinical Research Directory
Browse clinical research sites, groups, and studies.
Role of Microbiome in BCG Responsiveness Prediction
Sponsor: Cédric Poyet
Summary
Our primary aim is to investigate the use of microbial profile from the bladder and the feces of NMIBC patients as a predicting tool for therapy response prior to BCG administration. Our second aim is to collect additional samples (blood, instrumented urine, bladder tissue, feces) to establish a local biobank for future microbiome projects.
Official title: Towards Individualization of Bladder Cancer Therapy: the Role of Microbiome in BCG Responsiveness Prediction
Key Details
Gender
All
Age Range
18 Years - 90 Years
Study Type
OBSERVATIONAL
Enrollment
120
Start Date
2022-02-22
Completion Date
2025-10-20
Last Updated
2024-04-05
Healthy Volunteers
No
Conditions
Locations (5)
Kantonsspital Baden
Baden, Canton of Aargau, Switzerland
Spitalzentrum Biel
Biel/Bienne, Canton of Bern, Switzerland
Kantonsspital St. Gallen
Sankt Gallen, Canton of St. Gallen, Switzerland
Kantonsspital Winterthur
Winterthur, Canton of Zurich, Switzerland
University Hospital Zürich
Zurich, Switzerland